GlobeNewswire 3/23 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
GlobeNewswire 3/17 CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...
GlobeNewswire 3/1 CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...
GlobeNewswire 2/28 CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare Conference
GlobeNewswire 2/22 CytomX Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
GlobeNewswire 2/16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 1/20 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 1/19 CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for t...
GlobeNewswire 1/5 CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/20/2021 CytomX Therapeutics Announces Preliminary Results for Ongoing Phase 2 Expansion Study of CX-2029, a ...
GlobeNewswire 11/11/2021 CytomX Therapeutics to Present at Upcoming November Investor Conferences
GlobeNewswire 11/4/2021 CytomX Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire 11/1/2021 CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Cytokine Platform at Soc...
GlobeNewswire 10/28/2021 CytomX Therapeutics to Announce Third Quarter 2021 Financial Results on November 4, 2021
GlobeNewswire 10/18/2021 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 10/4/2021 CytomX Therapeutics Appoints Dr. Alan Ashworth to Board of Directors
GlobeNewswire 9/16/2021 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 9/7/2021 CytomX Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire 8/17/2021 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 8/5/2021 CytomX Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire 8/4/2021 CytomX Therapeutics Announces Multiple Publications on Pacmilimab (CX-072), a Conditionally Activate...
GlobeNewswire 8/2/2021 CytomX Therapeutics to Present at Upcoming August Investor Conferences
GlobeNewswire 7/29/2021 CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
GlobeNewswire 6/21/2021 CytomX Therapeutics Announces Publication of First-in-Human Data for CX-2029 in Clinical Cancer Rese...
GlobeNewswire 5/27/2021 CytomX Therapeutics to Present at Jefferies Virtual Healthcare Conference